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According to most investigators Hodgkin's disease is characterized from the 
immunological point of view by a disturbance of cellular immunity in the form 
of decreased Т-helper and increased Т-suppressor lymphocyte functional act i ­
v i t y (6, 9, 12). Single authors report also about a humoral immunity disorder in 
the form of altered immunoglobulin levels, especially during the recidives of 
illness (2, 4, 10). I n consideration of these data histamine role and participation 
in the pathogenesis of several diseases taking their course wi th immune system 
disorders is recently discussed (13). Our studies showed that blood histamine le­
v e l decreased significantly in Hodgkin's disease relapse but normalized in remis­
sion ( 1 , 8). These data demonstrated the necessity and advisabil i ty of paral le l 
follow-up of serum immunoglobulin levels in patients wi th Hodgkin's disease 
in relapse and remission. 
I n the present paper the results of a parallel study of histamine and serum 
I g G , IgA and IgM levels in Hodgkin's disease were discussed. A n attempt to eva­
luate their diagnostic and prognostic significance is made, too. 
Material and methods 
Blood histamine and serum immunoglobulin levels were determined wi th 
22 patients wi th mean age 30,5 years (in a range from 19 up to 54 years). 14 patients 
were in remission and 8 ones wi th relapse of the illness. The remission was a re­
sult of combined chemotherapy (Vincrist ine, Cyclophosphamide, Natulane, Pred­
nisolone) or radio/chemotherapy. These indexes were studied in 30 healthy indi­
viduals of the same age, too. Histamine was spectrophotometrically estimated 
after the method of W . Lorenz et a l . (7). Rad ia l immunodiffusion after Mancini 
was used for immunoglobulin determination. The data were processed stat is t i ­
cally after the methods of variat ion and correlation analyses. 
Results and discussion 
The mean blood histamine level was 0,088=0,007 ixg/ml in remission. I t 
did not differ significantly from that of the control group (0,072=0,002 ixg/ml — 
see table 1 and fig. 1). Histamine levels were higher than the differentiating rate 
as established by us for remission and relapse wi th a l l patients in remission 
(0,040 jig/ml) (1). Mean histamine rate was 0,028=0,005 ixg/ml in relapse. The 
comparative assessment showed that it was significantly reduced in relation to 
that of both the controls and the remission patients (p<0,001) . Serum globulin 
levels were studied parallelly in the same groups. 
Blood histamine level and serum. 
T a b l e 1 
Blood histamine and serum immunoglobulins in Hodgkin's disease 
Histamine mg/ml 
Serum immonuglobulins g/1 
IgG IgA IgM 
X Sx x Sx x Sx x s r 
H-D patients in 
remission n— 14 
0,087 0,008 18,13 2,60 2,26 0,40 0,99 0,13 
H-D patients in 
relapse 
n - 8 
0,028 0,005 11,06 2,03 1,65 0,57 0,17 0,10 
Control group 
n=30 







It can be seen on table 1 and fig. 2 that mean IgG rate was 18,13=2,60 g/ 
during remission, i . e. significantly increased as compared wi th that of the con" 
trols (p<0,05) . However, I gG reduction T 
in relapse was not s tat is t ical ly reliable 
in comparison wi th the control level of 
this immunoglobulin. 
Mean IgA rate was near to that of 
the controls when remission patients were 
considered. Its reduction during relapse 
down to 1,65=0,57 g/1 was not signifi­
cant (table 1 and fig. 2). 
IgM rate was 0 ,99=0,13 g/1 during 
remission and did not differ from that 
of the healthy individuals (table 1 and 
fig. 2) . The changes of IgM level were most 
considerable during relapse of the illness. 
The mean rate decreased down to 0,17 = 
=0,10 g/1 i . e. about 6 times as compa­
red wi th that of the controls (p<0,001). 
5 of the total of 8 patients in relapse show­
ed zero values. Other authors reported 
s imi lar data (2, 4, 10). According to 
them IgM reduced significantly in patients with dissemination of the process. 
T h e comparison of the data concerning histamine and serum immunoglobu­
l in 1 levels showed an unidirectionality of the changes during remission and re­
lapse. Histamine, IgA and IgM were near to the levels of the controls when remis­
sion was concerned. Only IgG levels were slightly increased. A l l indexes are low­
er than the control values during relapse. This reduction was especially wel l 
expressed and statist ically significant when histamine and IgM levels were con­
cerned, wi th 62 per cent and 84 per cent, respectively. I t was to be noted that 
these indexes had their lowest rates in patients in preterminal state. There exis­
ted a moderate direct correlation between both indexes (r—0,39). 
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Fig. 1. Blood histamine level in patients 
with Hodgkin's disease 
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A t this stage of investigation it was difficult to interpret the established in­
terrelation between histamine and IgM reduction during relapse of the disease. 
The restoration of IgA and IgM levels in remission up to that of the healthy 
persons, as wel l as IgG level increase could be in relation wi th lymphocyte count 
tgS IgA IgM 
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Fig. 2. Serum immunoglobulin levels in patients with Hodgkin's disease 
increase at this state as compared wi th that of the active stage of the illness that 
was observed by F . Herrmann et a l . (5). Besides, these authors reported B-cel l 
population augmentation above the control values and a slighter increase of T -
helper lymphocyte number. 
According to literature data available (11) histamine exerted, probably, a 
modulating function similar to that of Т-suppressor cells through which it could 
control the immune response. Furthermore, histamine act ivi ty was related wi th 
immunological reactivity in immune disorders (13). E . Berenyl et a l . (3) estab­
lished that the amount of both Т-cell subpopulations of peripheral T-lympho-
cytes increased significantly in Hodgkin's disease patients during relapse. The 
first one was wi th IgG Fc-receptors and the second wi th histamine receptors. 
Each subpopulation produced a suppressor substance. I t was l ikely that the in­
creased suppression act iv i ty of these two Т-cell subpopulations was responsible 
in the first place for the disturbance of the primary immune response manifested 
with predominant IgM reduction. 
I t could be assumed, on the other hand, that the disorder of immunological 
reactivi ty in Hodgkin's disease was related wi th an increased histamine turnover 
which determined this monoamine diminution in this sickness during relapse 
as we have already established. Reduced blood histamine and IgM levels could 
be used in complex with other appropriate indices as prognostic criteria. 
Blood histamine level and serum. 
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УРОВЕНЬ ГИСТАМИНА КРОВИ И СЫВОРОТОЧНЫХ 
ИММУНОГЛОБУЛИНОВ ПРИ БОЛЕЗНИ ХОЧКИНА 
А. Белчева, Р. Мишкова, Д . Желязков 
Р Е З Ю М Е 
Проведено параллельное исследование уровня гистамина крови, а также уровня иммуно­
глобулинов — ИгГ, ИгА и ИгМ у больных болезнью Хочкина во время рецидива и ремиссии 
заболевания. Установлено, что во время рецидива стоимости всех показателей, принятых в 
исследовании, ниже стоимостей тех же показателей у здоровых лиц в контрольной группе. 
Следует подчеркнуть, что наиболее выраженным и статистически значимым является пони­
жение уровня гистамина и ИгМ — соответственно на 62 % и 84 %. При ремисии и стоимости 
гистамина, ИгА и ИгМ близки к тем же стоимостям у здоровых лиц, а стоимости ИгГ несколь­
ко повышены. Обсуждается возможность использования показателей уровня гистамина 
крови и ИгМ (в комплексе с другими показателями) в качестве диагностических и прогнос­
тических критериев при рецидиве заболевания. 
